Identification of BST2 as a Biomarker for Alopecia Areata in Mice and Humans

This study identifies Bone marrow stromal antigen 2 (BST2) as a novel biomarker for alopecia areata, an autoimmune disease causing hair loss. Researchers found that BST2 is significantly upregulated in epidermal γδ T cells and dermal macrophages in both C3H/HeJ mice with alopecia areata and in human cases. The study highlights the role of BST2+CD11b+ macrophages in upregulating antiviral genes, suggesting a link between alopecia areata and viral particles. Additionally, BST2+ epidermal γδ T cells are associated with FAK signaling, indicating their involvement in the disease's pathogenesis. These findings suggest that BST2 plays a crucial role in alopecia areata through its interaction with specific immune cells.